The milestone strengthens MileCell’s U.S. business presence and supports opportunities to serve the federal research community. MileCell Biotechnology has completed its registration in the U.S. System for Award Management (SAM.gov), securing Active Registration status with an assigned Unique Entity ID (UEI) and Commercial and Government Entity (CAGE) Code. This milestone marks a step forward in […]
MileCell products are now listed on Tebubio’s website, providing an additional purchasing channel for life science researchers across Europe. MileCell Biotechnology announces that its products are now listed on the website of Tebubio, a European provider of life science research products and services. This collaboration expands MileCell’s distribution network and supports its continued efforts to […]
San Diego, CA — October 2026 — MileCell Biotechnology is pleased to announce that 70 prioritized MileCell product SKUs are now listed on Fisher Scientific, marking an important step in expanding access to MileCell’s biological research products across the U.S. scientific community. The newly listed products include product information and images, allowing researchers to discover […]
MileCell is pleased to announce its participation in the 27th North American ISSX Meeting, taking place October 11–14, 2026, at the Hilton San Francisco Union Square. The MileCell team will be exhibiting at Booth #200 and looks forward to connecting with researchers working across drug metabolism, DMPK, toxicology, and in vitro model development. Held under […]
MileCell Biotechnology today announced the appointment of FUJIFILM Wako Pure Chemical Corporation as its non-exclusive distributor in Japan under a new supplier-distributor agreement. Under the terms of the agreement, FUJIFILM Wako will distribute MileCell Biotechnology’s portfolio of animal-derived products, including peripheral blood mononuclear cells (PBMCs), hepatocytes, and non-parenchymal cells, across the Japanese life science market. […]
With EUROTOX 2026 just weeks away, MileCell Biotechnology is looking forward to joining the international toxicology community in Vienna from September 13–16, 2026. This year marks EUROTOX’s 60th Congress Anniversary, held under the theme “Toxicology without borders.” Toxicology increasingly asks more than whether a safety signal is present. Researchers also need to understand what drives […]
Translational immunology depends on experimental systems that can connect mechanistic findings with the biology of preclinical models. Animal peripheral blood mononuclear cells (PBMCs) are particularly useful in this role because they provide direct access to circulating mononuclear leukocytes while preserving the species and strain context of the in vivo model. For researchers comparing immune responses across discovery, […]
MileCell Biotechnology is pleased to announce its participation in the BIO International Convention 2026, taking place June 22–25 in San Diego, California. As one of the world’s premier biotechnology partnering events, BIO International Convention brings together biotechnology innovators, pharmaceutical companies, investors, service providers, and research organizations from around the globe. The event provides a unique […]
San Diego, CA — June 2026 MileCell Biotechnology is pleased to announce its membership in the 3Rs Collaborative (3RsC), a nonprofit organization dedicated to advancing better science for both people and animals through the principles of Refinement, Reduction, and Replacement (3Rs). The 3Rs Collaborative brings together stakeholders from industry, academia, government, and regulatory agencies to accelerate the […]
MileCell Biotechnology is pleased to announce its participation in the 2026 European ISSX Meeting, taking place June 29 – July 2, 2026. As one of the leading international conferences dedicated to drug metabolism, pharmacokinetics, and translational ADME sciences, ISSX Europe brings together researchers, scientists, and industry professionals focused on advancing more predictive and biologically relevant […]
